Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: jackie who wrote (10222)	5/27/1999 1:16:00 PM
From: Robert K.	Respond to of 17367

"Yes, by all means we must include the 62 patients in evaluating these unblinded results. If we do, it clearly indicates the bpi is working as it reinforces the assumed mortality rates for untreated cases.' > Exactly my point. Thats how I see it anyway. Will it prove true? We just have to wait and see. IMO Of course those 62 are just heresay anyway. We have no idea if even that is true or not. Standard K

To: jackie who wrote (10222)	5/27/1999 4:26:00 PM
From: aknahow	Read Replies (3) \| Respond to of 17367

Would not go quite that far, that the 62 should be used to evaluate the results. Yes I would use the 62 to speculate about the mortality rate for meningococcal sepsis. I have asked for clarification about what was said about the 62. If they were in the hospital and I would imagine that that is where the enrollment process starts, then it seems likely they were getting the standard of care normally provided and it they then died they become part of the group attended by the hospital of >8 and can probably be used to determine a rough mortality rate. but indirectly once I have done this and don't come up with some low mortality rate, I am using what I consider to be a more logical rate to formulate my opinion on effectiveness. Sorry for all the above stuff. I agree, but just would have worded it differently. But I agree with you because you agreed with me. <g>